CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,598,184 | -20.4% | 226,400 | +0.4% | 0.39% | -25.5% |
Q3 2022 | $5,779,000 | -2.4% | 225,400 | -9.5% | 0.52% | +10.1% |
Q2 2022 | $5,922,000 | +6.2% | 249,000 | +0.6% | 0.47% | +31.7% |
Q1 2022 | $5,576,000 | +72.8% | 247,600 | +33.5% | 0.36% | +13.9% |
Q3 2020 | $3,226,000 | +3.4% | 185,400 | 0.0% | 0.32% | +11.3% |
Q2 2020 | $3,119,000 | +136.1% | 185,400 | +130.9% | 0.28% | +54.3% |
Q1 2018 | $1,321,000 | -19.0% | 80,300 | -11.1% | 0.18% | -30.0% |
Q4 2017 | $1,631,000 | -6.4% | 90,300 | 0.0% | 0.26% | -10.5% |
Q3 2017 | $1,743,000 | +63.5% | 90,300 | 0.0% | 0.29% | +41.3% |
Q2 2017 | $1,066,000 | -5.8% | 90,300 | -12.6% | 0.21% | -7.6% |
Q1 2017 | $1,132,000 | – | 103,300 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |